Triple Negative Breast Cancer : On the Pathway to Better Outcomes | prIME Oncology

Untitled Document

Date and Location
08 October 2010 15.00 - 16.30 Fiera Milano City Floor -1; The Green Room Entrance: Viale Lodovico Scarampo 20145 Milan, Italy

Faculty
CHAIR Ian Smith, MD Royal Marsden Hospital London, United Kingdom FACULTY Nadia Harbeck, MD, PhD University of Cologne Cologne, Germany John Pippen, MD US Oncology Baylor Sammons Cancer Center Dallas, Texas, United States Giuseppe Viale, MD, PhD European Institute of Oncology and University of Milan Milan, Italy

Meeting Overview
On behalf of our chairman, Ian Smith, MD, we are pleased to invite you to our symposium “Triple-Negative Breast Cancer: On the Pathway to Better Outcomes” to be held during ESMO 2010 in Milan, Italy, on 8 October 2010. During this interactive meeting, leaders in the field will discuss clinical issues regarding triple-negative breast cancer.

Agenda

15.00		Welcome, introduction, and demographics Ian Smith, MD
15.05		Clinical opinion poll question
15.10		Understanding the biology of triple-negative breast cancer (TNBC) Giuseppe Viale, MD, PhD
15.25		Panel commentary
15.30		Clinical opinion poll question
15.35		Triple-negative breast cancer: What we know and what we don’t know Nadia Harbeck, MD, PhD
15.50		Panel commentary
15.55		Clinical opinion poll question
16.00		PARP inhibition: Why it works in TNBC John Pippen, MD
16.20		Panel commentary
16.25		Take home messages and future directions Ian Smith, MD

Printed Materials

Support
This activity is supported by sanofi-aventis